Close X
Attorney Spotlight

How did an interest in healthcare policy lead Robert Platt to a career in the law? Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

Envision to Sell to KKR for $9.9 Billion

We represented Envision Healthcare Corporation (NYSE: EVHC) in its definitive agreement to sell to KKR in an all-cash transaction for $9.9 billion, including debt. KKR will pay $46 per Envision share in cash to buy the company, marking a 32 percent premium to the company's volume-weighted average share price from November 1, when Envision announced it was considering its options. The transaction is expected to close the fourth quarter of 2018. Read more


Envision Healthcare

Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Six Things to Know Before Buying a Physician Practice spotlight

Dermatology, ophthalmology, radiology, urology…the list goes on. Yet, in any physician practice management transaction, there are six key considerations that apply and, if not carefully managed, can derail a transaction. Download the 6 Things to Know Before Buying a Physician Practice to keep your physician practice management transactions on track.

Click here to download the guide.

John L. Fuller

Member

Nashville
(615) 742-7921 TEL
(615) 248-4247 FAX

John L. Fuller

Member

Nashville
(615) 742-7921 TEL
(615) 248-4247 FAX
Nashville
(615) 742-7921 TEL
(615) 248-4247 FAX

John Fuller represents both established public and private companies as well as emerging start-ups across a range of industries including healthcare, media, food service, technology and manufacturing. In addition, John has counseled private equity and venture capital investment funds and their portfolio companies on more than $1 billion in mergers and acquisitions as well as numerous venture capital financing transactions.

John maintains a diverse corporate practice which involves:

  • Mergers and Acquisitions – Representing sellers and buyers in both public and private company transactions and has represented clients in numerous private equity and venture-backed purchase and sale transactions, including both leveraged and management buyouts across a variety of industry platforms.
  • Private Equity and Venture Capital Transactions – Advising clients in private equity and venture capital financings and portfolio management, including both company and investor side representation.

In addition to transactional work, John also regularly advises in general corporate governance matters, including fiduciary duties, securities law reporting and regulatory compliance and public company disclosure.

Memberships

American Bar Association — Business Law Section

American Health Lawyers Association (AHLA)

News

View More

Representative Experience

View More

Media Mentions

View More

Accolades

Mid-South Super Lawyers "Rising Star" (2016-2017)

Phi Kappa Phi

James Henry Burke and the H.L. Hendricks Memorial Scholarships

Certificate of Academic Excellence — Contract Drafting and Transactional Tax Planning

Transactions: The Tennessee Journal of Business Law

The Sally McDonnell Barksdale Honors College

Studied abroad at the University of Cambridge

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.